期刊文献+
共找到575篇文章
< 1 2 29 >
每页显示 20 50 100
Destabilization of acrosome and elastase influence mediate the release of secretory phospholipase A2 from human spermatozoa 被引量:2
1
作者 Jacqueline Leβig Uta Reibetanz +1 位作者 Jiirgen Arnhold Hans-Jtirgen Glander 《Asian Journal of Andrology》 SCIE CAS CSCD 2008年第6期829-836,共8页
Aim: To determine the cellular distribution of secretory phospholipase A2 (sPLA2) in dependence on the acrosomal state and under the action of elastase released under inflammatory processes from leukocytes. Methods... Aim: To determine the cellular distribution of secretory phospholipase A2 (sPLA2) in dependence on the acrosomal state and under the action of elastase released under inflammatory processes from leukocytes. Methods: Acrosome reaction of spermatozoa was triggered by calcimycin. Human leukocyte elastase was used to simulate inflammatory conditions. To visualize the distribution of sPLA2 and to determine the acrosomal state, immunofluorescence techniques and lectin binding combined with confocal laser scanning fluorescence microscopy and flow cytometry were used. Results: Although sPLA2 was detected at the acrosome and tail regions in intact spermatozoa, it disappeared from the head region after triggering the acrosome reaction. This release of sPLA2 was associated with enhanced binding of annexin V-fluoroscein isothiocyanate (FITC) to spermatozoa surfaces, intercalation of ethidium-homodimer I, and binding of FITC-labelled concanavalin A at the acrosomal region. Spermatozoa from healthy subjects treated with elastase were characterized by release of sPLA2, disturbance of acrosome structure, and loss of vitality. Conclusion: The ability of spermatozoa to release secretory phospholipase A2 is related to the acrosomal state. Premature destabi- lization of the acrosome and loss of sPLA2 can occur during silent inflammations in the male genital tract. The distribution pattern of sPLA2 in intact spermatozoa might be an additional parameter for evaluating sperm quality. 展开更多
关键词 acrosome reaction ELASTASE human spermatozoa INFLAMMATION secretory phospholipase a2
下载PDF
The key target of neuroprotection after the onset of ischemic stroke: secretory pathway Ca^(2+)-ATPase 1 被引量:13
2
作者 Li-hua Li Xiang-rong Tian Zhi-ping Hu 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第8期1271-1278,共8页
The regulatory mechanisms of cytoplasmic Ca2+ after myocardial infarction-induced Ca2+ overload involve secretory pathway Ca2+-ATPase 1 and the Golgi apparatus and are well understood. However, the effect of Golgi ... The regulatory mechanisms of cytoplasmic Ca2+ after myocardial infarction-induced Ca2+ overload involve secretory pathway Ca2+-ATPase 1 and the Golgi apparatus and are well understood. However, the effect of Golgi apparatus on Ca2+ overload after cerebral ischemia and reperfusion remains unclear. Four-vessel occlusion rats were used as animal models of cerebral ischemia. The expression of secretory pathway Ca2+-ATPase 1 in the cortex and hippocampus was detected by immunoblotting, and Ca2+ concentrations in the cytoplasm and Golgi vesicles were determined. Results showed an overload of cytoplasmic Ca2+ during ischemia and reperfusion that reached a peak after reperfusion. Levels of Golgi Ca2+ showed an opposite effect. The expression of Golgi-specific secretory pathway Ca2+-ATPase 1 in the cortex and hippocampus decreased before ischemia and reperfusion, and increased after reperfusion for 6 hours. This variation was similar to the alteration of calcium in separated Golgi vesicles. These results indicate that the Golgi apparatus participates in the formation and alleviation of calcium overload, and that secretory pathway Ca2+-ATPase 1 tightly responds to ischemia and reperfusion in nerve cells. Thus, we concluded that secretory pathway Ca2+-ATPase 1 plays an essential role in cytosolic calcium regulation and its expression can be used as a marker of Golgi stress, responding to cerebral ischemia and reperfusion. The secretory pathway Ca2+-ATPase 1 can be an important neuroprotective target of ischemic stroke. 展开更多
关键词 nerve regeneration brain injury global cerebral ischemia Golgi apparatus Golgi stress cytoplasmic Ca2 homeostasis Golgi Ca2 Ca2 pump secretory pathway Ca2+-ATPase 1 neural protection NSFC grant neural regeneration
下载PDF
Changes in secretory pathway Ca^(2+)-ATPase 2 following focal cerebral ischemia/reperfusion injury 被引量:2
3
作者 Tonglin Lu Zhiping Hu +1 位作者 Liuwang Zeng Zheng Jiang 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第1期76-82,共7页
This study aimed to investigate changes in secretory pathway Ca2+-ATPase 2 expression following cerebral ischemia/reperfusion injury, and to define the role of Ca2+-ATPases in oxidative stress. A rat model of cerebr... This study aimed to investigate changes in secretory pathway Ca2+-ATPase 2 expression following cerebral ischemia/reperfusion injury, and to define the role of Ca2+-ATPases in oxidative stress. A rat model of cerebral ischemia/reperfusion injury was established using the unilateral middle cerebral artery occlusion method. Immunohistochemistry and reverse transcription-PCR assay results showed that compared with the control group, the expression of secretory pathway Ca2+-ATPase 2 protein and mRNA in the cerebral cortex and hippocampus of male rats did not significantly change during the ischemic period. However, secretory pathway Ca2+-ATPase 2 protein and mRNA expression reduced gradually at 1, 3, and 24 hours during the reperfusion period. Our experimental findings indicate that levels of secretory pathway Ca2+-ATPase 2 protein and mRNA expression in brain tissue change in response to cerebral ischemia/reperfusion injury. 展开更多
关键词 neural regeneration brain injury cerebral infarction secretory pathway Ca2+-ATPase 2 Golgiapparatus Ca2 oscillations manganese focal cerebral ischemia oxidative damage Ca2^-ATPase grants-supported paper photographs-containing paper NEUROREGENERATION
下载PDF
穿山龙总皂苷对膜性肾病大鼠肾组织M型PLA2R和IgG4表达的影响及其机制
4
作者 杨薇 平高华 +2 位作者 张峥 姚吉太 刘光珍 《世界中西医结合杂志》 2024年第2期274-280,共7页
目的 分析穿山龙总皂苷对膜性肾病大鼠肾组织M型磷脂酶A2受体(Phospholipase A2 receptor, PLA2R)和免疫球蛋白G亚型4(Immunoglobulin G4,IgG4)表达影响及可能机制。方法 将40只SPF级雄性SD大鼠按随机数字表法分为对照组、模型组、贝那... 目的 分析穿山龙总皂苷对膜性肾病大鼠肾组织M型磷脂酶A2受体(Phospholipase A2 receptor, PLA2R)和免疫球蛋白G亚型4(Immunoglobulin G4,IgG4)表达影响及可能机制。方法 将40只SPF级雄性SD大鼠按随机数字表法分为对照组、模型组、贝那普利组(10 mg/kg)、低和高剂量穿山龙总皂苷组(80 mg/kg、160 mg/kg),每组各8只。除对照组,其余4组采用Border法制备膜性肾病模型,造模成功后,贝那普利组灌胃给予贝那普利10 mg/(kg·d),低和高剂量穿山龙总皂苷组分别灌胃给予穿山龙总皂苷80 mg/(kg·d)、160 mg/(kg·d),对照组、模型组灌胃给予10 ml/(kg·d)生理盐水。连续给药4周后,检测24 h尿蛋白、白蛋白、血肌酐、血尿素氮、尿酸水平,HE染色观察肾脏病理改变,蛋白免疫印迹法检测肾脏中M型PLA2R、IgG4、磷酸化磷脂酰肌醇3-激酶(Phosphorylated phosphoinositide 3-kinase, p-PI3K)、磷酸化蛋白激酶B(Phosphorylated protein kinase B,p-AKT)、核因子E2相关因子2(Nuclear factor E2-related factor 2,Nrf2)、血红素加氧酶(Heme oxygenase-1,HO-1)表达水平。结果 与模型组比较,贝那普利组、高剂量穿山龙总皂苷组白蛋白水平明显升高,血肌酐、血尿素氮、尿酸水平明显降低,差异均有统计学意义(P>0.05)。与模型组比较,贝那普利组、低剂量和高剂量穿山龙总皂苷组肾脏病理改变明显改善,24 h尿蛋白水平及肾脏中M型PLA2R、IgG4、p-PI3K、p-AKT表达水平明显降低,肾脏中Nrf2、HO-1表达水平明显增加,差异均有统计学意义(P<0.05)。结论 穿山龙总皂苷对膜性肾病大鼠的肾脏具有保护作用,其机制可能与降低PLA2R、IgG4表达,抑制PI3K/AKT通路,激活Nrf2/HO-1通路相关。 展开更多
关键词 膜性肾病 穿山龙总皂苷 磷脂酶a2受体 免疫球蛋白G亚型4 磷脂酰肌醇3-激酶/蛋白激酶B通路 核因子E2相关因子2/血红素加氧酶通路
下载PDF
The small GTPase RABA2a recruits SNARE proteins to regulate the secretory pathway in parallel with the exocyst complex in Arabidopsis 被引量:3
5
作者 Lei Pang Zhiming Ma +4 位作者 Xi Zhang Yuanzhi Huang Ruili Li Yansong Miao Ruixi Li 《Molecular Plant》 SCIE CAS CSCD 2022年第3期398-418,共21页
Delivery of proteins to the plasma membrane occurs via secretion,which requires tethering,docking,priming,and fusion of vesicles.In yeast and mammalian cells,an evolutionarily conserved RAB GTPase activation cascade f... Delivery of proteins to the plasma membrane occurs via secretion,which requires tethering,docking,priming,and fusion of vesicles.In yeast and mammalian cells,an evolutionarily conserved RAB GTPase activation cascade functions together with the exocyst and SNARE proteins to coordinate vesicle transport with fusion at the plasma membrane.However,it is unclear whether this is the case in plants.In this study,we show that the small GTPase RABA2a recruits and interacts with the VAMP721/722-SYP121-SNAP33 SNARE ternary complex for membrane fusion.Through immunoprecipitation coupled with mass spectrometry analysis followed by the validatation with a series of biochemical assays,we identified the SNARE proteins VAMP721 and SYP121 as the interactors and downstream effectors of RABA2a.Further expreiments showed that RABA2a interacts with all members of the SNARE complex in its GTP-bound form and modulates the assembly of the VAMP721/722-SYP121-SNAP33 SNARE ternary complex.Intriguingly,we did not observe the interaction of the exocyst subunits with either RABA2a or theSNARE proteins in several different experiments.Neither RABA2a inactivation affects the subcellular localization or assembly of the exocystnor the exocyst subunit mutant exo84b shows the disrupted RABA2a-SNARE association or SNARE assembly,suggesting that the RABA2a-SNARE-and exocyst-mediated secretory pathways are largely independent.Consistently,our live imaging experiments reveal that the two sets of proteins follow non-overlapping trafficking routes,and genetic and cell biologyanalyses indicate that the two pathways select different cargos.Finally,we demonstrate that the plant-specific RABA2a-SNARE pathway is essential for the maintenance of potassium homeostasis in Arabisopsis seedlings.Collectively,our findings imply that higher plants might have generated different endomembrane sorting pathways during evolution and may enable the highly conserved endomembrane proteins to participate in plant-specific trafficking mechanisms for adaptation to the changing environment. 展开更多
关键词 EXOCYST RABa2a secretory process SNARE complex
原文传递
Design, Synthesis, and Biological Evaluation of Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase
6
作者 Xing Gao Haojun Gong +2 位作者 Peng Men Lu Zhou Deyong Ye 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2013年第9期1164-1170,共7页
A novel series of eight SMS and sPLA2 dual inhibitors containing indole and a-amino cyanide fragments of different length and substitution position was synthesized and evaluated by three different in vitro assays. Bio... A novel series of eight SMS and sPLA2 dual inhibitors containing indole and a-amino cyanide fragments of different length and substitution position was synthesized and evaluated by three different in vitro assays. Biological evaluation showed that all compounds provided inhibitory effects against SMS (about 50% inhibition at 100 μmol/L) and sPLA2 (14-32 μmol/L). All the compounds had the SMS activity better than the positive control compound D609 in SMS2 homogenate, with compounds 5b and fie ideal for liver homogenate and SMS2 high expression cell homogenate, respectively. 展开更多
关键词 ATHEROSCLEROSIS secretory phospholipase a2 (sPLa2 sphingomyelin synthase (SMS) multi-targetdrug design dual inhibitors
原文传递
Elevated serum secretory type Ⅱ phospholipase A2 in patients with coronary heart disease
7
作者 于路 《China Medical Abstracts(Internal Medicine)》 2006年第4期207-207,共1页
Objective To measure the serum level of secretory type H phospholipase A2 (sPLA2) in patients with coronary heart disease and investigate the possible relationship with IL-8 and LPA. Methods A total of 110 patients wi... Objective To measure the serum level of secretory type H phospholipase A2 (sPLA2) in patients with coronary heart disease and investigate the possible relationship with IL-8 and LPA. Methods A total of 110 patients with acute coronary syndrome (ACS) , 63 patients with stable coronary heart disease (SCHD) group and 89 non-CHD control patients were studied. Serum levels of sPLA2, IL-8, LPA and hs-CRP were measured and 展开更多
关键词 PHOSPHOLIPASE secretory SERUM
原文传递
Mogroside IIE,an in vivo metabolite of sweet agent,alleviates acute lung injury via Pla2g2a-EGFR inhibition
8
作者 Weichao Lü Guoqing Ren +2 位作者 Kuniyoshi Shimizu Renshi Li Chaofeng Zhang 《Food Science and Human Wellness》 SCIE CSCD 2024年第1期299-312,共14页
In the face of increasingly serious environmental pollution,the health of human lung tissues is also facing serious threats.Mogroside IIE(M2E)is the main metabolite of sweetening agents mogrosides from the anti-tussiv... In the face of increasingly serious environmental pollution,the health of human lung tissues is also facing serious threats.Mogroside IIE(M2E)is the main metabolite of sweetening agents mogrosides from the anti-tussive Chinese herbal Siraitia grosvenori.The study elucidated the anti-inflammatory action and molecular mechanism of M2E against acute lung injury(ALI).A lipopolysaccharide(LPS)-induced ALI model was established in mice and MH-S cells were employed to explore the protective mechanism of M2E through the western blotting,co-immunoprecipitation,and quantitative real time-PCR analysis.The results indicated that M2E alleviated LPS-induced lung injury through restraining the activation of secreted phospholipase A2 type IIA(Pla2g2a)-epidermal growth factor receptor(EGFR).The interaction of Pla2g2a and EGFR was identified by co-immunoprecipitation.In addition,M2E protected ALI induced with LPS against inflammatory and damage which were significantly dependent upon the downregulation of AKT and m TOR via the inhibition of Pla2g2a-EGFR.Pla2g2a may represent a potential target for M2E in the improvement of LPS-induced lung injury,which may represent a promising strategy to treat ALI. 展开更多
关键词 Mogroside IIE Acute lung injury Secreted phospholipase a2 type IIA(Pla2g2a) Epidermal growth factor receptor(EGFR)
下载PDF
Plasma Lysophosphatidylcholine and Phospholipase A2 Activity in Chagas Disease Patients: A Comparative Analysis
9
作者 Maria Fernanda Carvalho de Araujo Bruna Maria Ferreira Iaciura +1 位作者 Fillipe Araujo de Sá Georgia Correa Atella 《Advances in Bioscience and Biotechnology》 CAS 2024年第8期462-473,共12页
Chagas disease (CD) affects 21 countries in the Americas and is caused by the parasite Trypanosoma cruzi. A key molecule involved in CD is lysophosphatidylcholine (LPC), which has been studied in various contexts: in ... Chagas disease (CD) affects 21 countries in the Americas and is caused by the parasite Trypanosoma cruzi. A key molecule involved in CD is lysophosphatidylcholine (LPC), which has been studied in various contexts: in the saliva of insect vectors, during the establishment of infection in the vertebrate host, and for the parasite itself. This lipid can be produced by the action of phospholipases A2 (PLA2), enzymes that catalyze the hydrolysis of phospholipids releasing fatty acids and lysophospholipids, such as LPC. This study investigates LPC levels and PLA2 activities in the plasma of CD patients and compares these levels with those in healthy individuals and patients with idiopathic dilated cardiomyopathy (IDCM). Plasma from 64 CD patients, 54 healthy individuals, and 16 IDCM patients were analyzed. LPC levels and the activity of two types of phospholipase A2: secreted (sPLA2) and lipoprotein-associated (Lp-PLA2) were measured. LPC levels and sPLA2 activity were similar between CD patients and the control groups. However, there were notable differences in LPC levels and sPLA2 activity between subgroups of CD patients and IDCM patients. This study is the first to identify LPC in patients with CD across various stages of the disease. It also offers new insights into the biochemical changes observed in the plasma of patients with IDCM. 展开更多
关键词 LYSOPHOSPHATIDYLCHOLINE Phospholipase a2 PLASMA Chagas Disease Idiopathic Dilated Cardiomyopathy
下载PDF
In Silico Screening of Potential Inhibitors against dPLA2 from Named Chinese Herbs for Identification of Compounds with Antivenom Effects Due to Deinagkistrodon acutus Snake Bites
10
作者 Xingyang Xiao Mengyi Lai +3 位作者 Zechang Rao Jianzhong Huang Yiwei Xie Hongbin Zhang 《American Journal of Molecular Biology》 CAS 2024年第3期107-125,共19页
Phospholipase A2 (PLA2) is the key enzyme to the venom from Deinagkistrodon acutus which is one of the highly venomous snakes in China. In addition to being a catalyst for the hydrolysis of phospholipases A2 from snak... Phospholipase A2 (PLA2) is the key enzyme to the venom from Deinagkistrodon acutus which is one of the highly venomous snakes in China. In addition to being a catalyst for the hydrolysis of phospholipases A2 from snake venom, its well known that it possesses a broad spectrum of pharmacological activities, such as myotoxicity, neurotoxicity, cardiotoxicity, and hemolytic, anticoagulant and antiplatelet activities. However, snakebites are not efficiently treated by conventional serum therapy. Acute wounds can still cause poisoning and death. In order to find effective inhibitors of Deinagkistrodon venom acid phospholipase A2 (dPLA2), we obtained 385 compounds in 9 Chinese herbs from the TCMSP. These compounds were further performed to virtual screen using in silico tools like ADMET analysis, molecular docking and molecular dynamics (MD) simulation. After Pharmacokinetics analysis, we found 7 candidate compounds. Besides, analysis of small molecule interactions with dPLA2 confirmed that the amino acid residues HIS47 and GLY29 are key targets. Because they bind not only to the natural substrate phosphatidylcholine and compounds known for having inhibitory functions, but also for combining with potential antidote molecules in Chinese herbal medicine. This study is the first to report experience with virtual screening for possible inhibitor of dPLA2, such as the interaction spatial structure, binding energy and binding interaction analysis, these experiences not only provide reference for further experimental research, but also have a guideline for the study of drug molecular mechanism of action. 展开更多
关键词 Chinese Herbal Medicine Phospholipase a2 Inhibitor Molecular Docking Molecular Mechanism
下载PDF
Link between mutations in ACVRL1 and PLA2G4A genes and chronic intestinal ulcers:A case report and review of literature
11
作者 Yong-Jing Tang Jian Zhang +7 位作者 Jie Wang Ren-Dong Tian Wei-Wei Zhong Ben-Sheng Yao Bing-Yu Hou Ying-Hua Chen Wei He Yi-Huai He 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第3期932-943,共12页
BACKGROUND Genetic factors of chronic intestinal ulcers are increasingly garnering attention.We present a case of chronic intestinal ulcers and bleeding associated with mu-tations of the activin A receptor type II-lik... BACKGROUND Genetic factors of chronic intestinal ulcers are increasingly garnering attention.We present a case of chronic intestinal ulcers and bleeding associated with mu-tations of the activin A receptor type II-like 1(ACVRL1)and phospholipase A2 group IVA(PLA2G4A)genes and review the available relevant literature.CASE SUMMARY A 20-year-old man was admitted to our center with a 6-year history of recurrent abdominal pain,diarrhea,and dark stools.At the onset 6 years ago,the patient had received treatment at a local hospital for abdominal pain persisting for 7 d,under the diagnosis of diffuse peritonitis,acute gangrenous appendicitis with perforation,adhesive intestinal obstruction,and pelvic abscess.The surgical treat-ment included exploratory laparotomy,appendectomy,intestinal adhesiolysis,and pelvic abscess removal.The patient’s condition improved and he was dis-charged.However,the recurrent episodes of abdominal pain and passage of black stools started again one year after discharge.On the basis of these features and results of subsequent colonoscopy,the clinical diagnosis was established as in-flammatory bowel disease(IBD).Accordingly,aminosalicylic acid,immunotherapy,and related symptomatic treatment were administered,but the symptoms of the patient did not improve significantly.Further investigations revealed mutations in the ACVRL1 and PLA2G4A genes.ACVRL1 and PLA2G4A are involved in angiogenesis and coagulation,respectively.This suggests that the chronic intestinal ulcers and bleeding in this case may be linked to mutations in the ACVRL1 and PLA2G4A genes.Oral Kangfuxin liquid was administered to promote healing of the intestinal mucosa and effectively manage clinical symptoms.CONCLUSION Mutations in the ACVRL1 and PLA2G4A genes may be one of the causes of chronic intestinal ulcers and bleeding in IBD.Orally administered Kangfuxin liquid may have therapeutic potential. 展开更多
关键词 Intestinal ulcers Crohn’s disease Ulcerative colitis Activin A receptor type II-like 1 Phospholipase a2 group 4A Case report
下载PDF
血清CCSP、sPLA2、CRP水平在肺炎支原体肺炎患儿中的变化及临床价值
12
作者 王营营 王梦 王豪 《哈尔滨医药》 2024年第5期11-14,共4页
目的分析肺炎支原体肺炎(MPP)患儿血清Clara细胞分泌蛋白(CCSP)、分泌型磷脂酶A2(sPLA2)、C反应蛋白(CRP)水平变化,并探讨其对预后的评估价值。方法回顾性选取105例MPP患儿为研究组,另选取同期健康儿童35例作为对照组。比较两组临床指... 目的分析肺炎支原体肺炎(MPP)患儿血清Clara细胞分泌蛋白(CCSP)、分泌型磷脂酶A2(sPLA2)、C反应蛋白(CRP)水平变化,并探讨其对预后的评估价值。方法回顾性选取105例MPP患儿为研究组,另选取同期健康儿童35例作为对照组。比较两组临床指标及血清CCSP、sPLA2、CRP水平。依据病情严重程度将研究组患儿分为轻症64例、重症41例,比较其血清CCSP、sPLA2、CRP水平及临床肺部感染评分(CPIS)。分析血清CCSP、sPLA2、CRP与临床指标、CPIS评分相关性。研究组予以常规治疗10 d,依据预后情况分为预后不良25例、预后良好80例,比较其治疗前、治疗3 d后血清CCSP、sPLA2、CRP水平。分析治疗3 d后血清CCSP、sPLA2、CRP对治疗10 d预后的评估价值。结果研究组白细胞计数、中性粒细胞计数、红细胞沉降率高于对照组,淋巴细胞计数低于对照组(P<0.05);研究组血清CCSP水平低于对照组,血清sPLA2、CRP水平高于对照组(P<0.05);重症者血清CCSP水平低于轻症者,血清sPLA2、CRP水平及CPIS评分高于轻症者(P<0.05);血清CCSP与白细胞计数、中性粒细胞计数、红细胞沉降率、CPIS评分、病情程度呈负相关,血清sPLA2、CRP与之相反(P<0.05);预后不良者治疗3 d后血清CCSP水平低于预后良好者,血清sPLA2、CRP水平高于预后良好者(P<0.05);血清CCSP、sPLA2、CRP联合评估预后的AUC大于单项指标评估(P<0.05)。结论MPP患儿血清CCSP水平降低,血清sPLA2、CRP水平升高,且与病情程度密切相关,联合检测其水平对MPP患儿预后具有一定评估价值。 展开更多
关键词 肺炎支原体肺炎 CLARA细胞分泌蛋白 分泌型磷脂酶a2 C反应蛋白 预后
下载PDF
达格列净对2型糖尿病肾病患者血清脂蛋白相关磷脂酶A2及肾损伤标志物的影响
13
作者 方葆娇 何江 +1 位作者 尧波 朱柏林 《当代医学》 2024年第4期47-50,共4页
目的分析达格列净对2型糖尿病肾病患者血清脂蛋白相关磷脂酶A2(Lp-PLA2)及肾损伤标志物的影响。方法选取2020年2月至2021年6月抚州市中医院收治的90例2型糖尿病肾病患者作为研究对象,随机分为对照组与研究组,每组45例。对照组给予二甲... 目的分析达格列净对2型糖尿病肾病患者血清脂蛋白相关磷脂酶A2(Lp-PLA2)及肾损伤标志物的影响。方法选取2020年2月至2021年6月抚州市中医院收治的90例2型糖尿病肾病患者作为研究对象,随机分为对照组与研究组,每组45例。对照组给予二甲双胍片治疗,研究组给予达格列净治疗,比较两组治疗前后血糖水平、血清Lp-PLA2水平及肾损伤标志物。结果治疗后,两组糖化血红蛋白A1c(HbA1c)、空腹血糖(FBG)、餐后2h血糖(2hPBG)水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组血清Lp-PLA2水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组尿素氮(BUN)水平、尿微量白蛋白与尿肌酐比值(ACR)均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05)。结论采用达格列净治疗2型糖尿病肾病患者疗效显著,能有效控制血糖水平,显著改善血管内皮功,有效减轻肾损伤程度,显著改善患者肾功能,值得临床推广应用。 展开更多
关键词 达格列净 2型糖尿病 肾病 脂蛋白相关磷脂酶a2 肾损伤
下载PDF
血清LP-PLA2和MMP-9水平与2型糖尿病合并脑梗死患者颈动脉斑块易损性的相关性
14
作者 董兰真 孙学瑞 +2 位作者 吴婧 于洋 刘鹏 《临床和实验医学杂志》 2024年第18期1916-1920,共5页
目的 探讨血清脂蛋白相关磷脂酶A2(LP-PLA2)、基质金属蛋白酶-9(MMP-9)水平与2型糖尿病合并脑梗死患者颈动脉斑块易损性的相关性。方法 回顾性研究2020年2月至2023年1月在沧州市人民医院住院治疗的102例2型糖尿病合并脑梗死患者的临床资... 目的 探讨血清脂蛋白相关磷脂酶A2(LP-PLA2)、基质金属蛋白酶-9(MMP-9)水平与2型糖尿病合并脑梗死患者颈动脉斑块易损性的相关性。方法 回顾性研究2020年2月至2023年1月在沧州市人民医院住院治疗的102例2型糖尿病合并脑梗死患者的临床资料,根据粥样斑块性质分组:50例患者为颈动脉斑块易损(易损组),52例患者为稳定性颈动脉斑块(稳定组)。对比不同颈动脉斑块易损性患者的各项影响因素(性别、年龄、体重指数、合并高血压、合并高血脂症、血糖、血脂等);采用多因素Logistics回归分析影响颈动脉斑块易损性的因素;并以受试者操作特征(ROC)分析LP-PLA2、MMP-9单独及联合检查对颈动脉斑块易损性的预测价值。结果 稳定组与易损组患者的性别构成比、年龄、体重指数、合并高血压、合并高血脂症、甘油三酯、高密度脂蛋白胆固醇(HDL-C)比较,差异均无统计学意义(P>0.05),易损组患者的空腹血糖、HbA1c、总胆固醇、低密度脂蛋白胆固醇(LDL-C)、LP-PLA2、MMP-9水平分别为(6.19±0.88) mmol/L、(10.21±1.16)%、(4.87±0.87) mmol/L、(2.90±0.45) mmol/L、(363.16±52.78) pg/L、(83.36±11.29) pg/L,均明显高于稳定组[(5.81±0.44) mmol/L、(9.71±1.21)%、(4.51±0.55) mmol/L、(2.44±0.33) mmol/L、(292.44±47.27)pg/L、(60.46±9.85) pg/L],差异均有统计学意义(P<0.05)。多因素Logistics回归分析结果显示,HbA1c、LP-PLA2、MMP-9确定为影响2型糖尿病合并脑梗死患者颈动脉斑块易损性的独立因素(P<0.05)。LP-PLA2、MMP-9单独及联合检查预测颈动脉斑块易损性均有较高的准确性(P<0.05)。结论 糖尿病类型2合并脑梗死的患者颈动脉中存在不稳定的斑块的风险较高,而联合应用LP-PLA2与MMP-9作为标志物,对于颈动脉不稳定斑块的稳定性显现出较好的预测效果。 展开更多
关键词 脂蛋白相关磷脂酶a2 基质金属蛋白酶-9 2型糖尿病 脑梗死 颈动脉斑块易损性
下载PDF
维持性血液透析患者心脏瓣膜钙化与血清脂蛋白相关磷脂酶A2的关系
15
作者 陆飞 沈雷 +2 位作者 沈雁君 黄力 袁卫东 《南通大学学报(医学版)》 2024年第3期253-256,共4页
目的:探讨血清脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase 2,Lp-PLA2)水平与维持性血液透析(maintenance hemodialysis,MHD)患者心脏瓣膜钙化(cardiac valve calcification,CVC)的关系。方法:随机抽取MHD患者100例,根据... 目的:探讨血清脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase 2,Lp-PLA2)水平与维持性血液透析(maintenance hemodialysis,MHD)患者心脏瓣膜钙化(cardiac valve calcification,CVC)的关系。方法:随机抽取MHD患者100例,根据心脏彩色多普勒超声检查评估患者是否发生CVC分为CVC组(44例)与非CVC组(56例)。比较两组临床特征及实验室指标,采用多因素Logistic回归分析CVC发生的影响因素,绘制ROC曲线分析Lp-PLA2对CVC的预测价值。结果:100例MHD患者中的CVC发病率为44%;CVC组年龄、透析龄、血清Lp-PLA2水平均高于非CVC组(均P<0.05)。多因素Logistic回归分析结果显示,高龄、透析龄长、血清Lp-PLA2升高是MHD患者发生CVC的独立危险因素(P<0.05)。ROC曲线显示,Lp-PLA2预测MHD患者发生CVC的AUC为0.840(P<0.05),具有较高的预测价值。结论:血清Lp-PLA2升高是MHD患者发生CVC的危险因素,可能成为预测MHD患者CVC发生的重要生物学标志物。 展开更多
关键词 维持性血液透析 脂蛋白相关磷脂酶a2 心脏瓣膜钙化
下载PDF
血清sPLA2-X、Copeptin水平对老年重症支气管扩张合并感染患者疗效的预测作用
16
作者 邢秋棠 林清荣 张凤芸 《生命科学仪器》 2024年第3期84-86,90,共4页
目的探讨分析血清分泌型磷脂酶A2-X(sPLA2-X)与和肽素(Copeptin)水平对老年重症支气管扩张合并感染患者临床治疗效果的预测作用。方法选取2022年1月至2023年12月淄博市张店区人民医院收治的重症支气管扩张合并感染患者132例,检测血清sPL... 目的探讨分析血清分泌型磷脂酶A2-X(sPLA2-X)与和肽素(Copeptin)水平对老年重症支气管扩张合并感染患者临床治疗效果的预测作用。方法选取2022年1月至2023年12月淄博市张店区人民医院收治的重症支气管扩张合并感染患者132例,检测血清sPLA2-X、Copeptin水平。使用临床肺部感染评分(CPIS)进行病情严重程度评价,分析血清sPLA2-X、Copeptin水平与CPIS评分的相关性。患者入院后,均给予对症治疗,根据治疗效果分为治疗有效组和无效组。分析血清sPLA2-X、Copeptin水平对老年重症支气管扩张合并感染患者疗效的预测价值。结果Pearson相关性分析结果显示,血清sPLA2-X、Copeptin水平与CPIS评分均呈正相关,P<0.05。治疗有效组患者血清sPLA2-X、Copeptin水平均高于无效组,P<0.05;经受试者工作特征曲线(ROC)显示,sPLA2-X预测治疗有效的曲线面积(AUC)为0.838,Copeptin的AUC为0.807,二者联合的AUC为0.904,高于sPLA2-X、Copeptin单独预测,P<0.05。结论老年重症支气管扩张合并感染患者的血清sPLA2-X、Copeptin水平与感染程度密切相关,在疗效预测中具有较高应用价值,可考虑用于该病患者的诊疗和预后判断。 展开更多
关键词 支气管扩张 肺部感染 分泌型磷脂酶a2-X 和肽素
下载PDF
血清Lp-PLA2、sIL-2R、PCT在肺炎支原体肺炎患者中的表达及对预后的预测价值
17
作者 李玉梅 赵雪 《航空航天医学杂志》 2024年第10期1166-1169,共4页
目的探究肺炎支原体肺炎(MPP)患者血清脂蛋白磷脂酶A2(Lp-PLA2)、可溶性白细胞介素-2受体(sIL-2R)、降钙素原(PCT)水平变化及其对预后的预测价值。方法纳入2021年05月~2023年05月本院收治的82例成人MPP患者设为研究组,同期于本院体检的... 目的探究肺炎支原体肺炎(MPP)患者血清脂蛋白磷脂酶A2(Lp-PLA2)、可溶性白细胞介素-2受体(sIL-2R)、降钙素原(PCT)水平变化及其对预后的预测价值。方法纳入2021年05月~2023年05月本院收治的82例成人MPP患者设为研究组,同期于本院体检的健康志愿者82例设为对照组。比较两组血清Lp-PLA2、sIL-2R、PCT水平及肺功能[潮气量(VT)、达峰时间比(tPTEF/TE)、呼出75%潮气量时间的瞬间流速/潮气呼气峰流速(TEF25/PTEF%)]。依据病情严重程度分为轻症者46例、重症者36例,比较其各血清指标水平及临床肺部感染评分(CPIS)、改良版英国医学研究委员会呼吸困难量表(mMRC)评分。分析血清Lp-PLA2、sIL-2R、PCT与肺功能、CPIS评分、mMRC评分、病情严重程度相关性。依据治疗后3周内预后情况分为预后不良者、预后良好者,比较治疗前、治疗3 d后血清Lp-PLA2、sIL-2R、PCT水平。采用受试者工作特征曲线(ROC)分析治疗3 d后各血清指标对预后不良的预测价值。结果研究组血清Lp-PLA2、sIL-2R、PCT水平高于对照组,VT、tPTEF/TE、TEF25/PTEF%低于对照组(P<0.05);重症者血清Lp-PLA2、sIL-2R、PCT水平及CPIS评分、mMRC评分高于轻症者(P<0.05);血清Lp-PLA2、sIL-2R、PCT与tPTEF/TE呈负相关,而与CPIS评分、mMRC评分、病情严重程度呈正相关(P<0.05);预后不良者血清Lp-PLA2、sIL-2R、PCT水平高于预后良好者(P<0.05);血清Lp-PLA2、sIL-2R、PCT联合预测预后不良的AUC大于单独指标预测(P<0.05)。结论MPP患者血清Lp-PLA2、sIL-2R、PCT水平升高,且与肺功能、病情严重程度密切相关,联合检测其水平对预后具有一定预测价值。 展开更多
关键词 肺炎支原体肺炎 脂蛋白磷脂酶a2 可溶性白细胞介素-2受体 降钙素原
下载PDF
血清FFA、IL-37和Lp-PLA2与2型糖尿病患者血管内皮损伤的相关性研究
18
作者 李真 申敏 +1 位作者 张新焕 刘庆华 《中国医药科学》 2024年第13期125-128,132,共5页
目的探讨2型糖尿病(T2DM)患者血清中游离脂肪酸(FFA)、白细胞介素-37(IL-37)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平变化与血管内皮损伤的相关性。方法本研究选取山东第一医科大学第二附属医院(本院)2023年1—6月收治T2DM患者113例为T2DM组... 目的探讨2型糖尿病(T2DM)患者血清中游离脂肪酸(FFA)、白细胞介素-37(IL-37)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平变化与血管内皮损伤的相关性。方法本研究选取山东第一医科大学第二附属医院(本院)2023年1—6月收治T2DM患者113例为T2DM组(试验组),选择同期在本院健康查体者113名为健康组(对照组),检测两组的血脂指标、血糖指标及血管内皮损伤指标进行统计分析。结果T2DM组的空腹血糖(FPG)、游离脂肪酸(FFA)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、低密度脂蛋白(LDL)、IL-37及Lp-PLA2水平均高于健康组,一氧化氮(NO)水平低于健康组,差异有统计学意义(P<0.05);两组总胆固醇(TC)、高密度脂蛋白(HDL)比较,差异无统计学意义(P>0.05)。T2DM组FFA、IL-27和Lp-PLA2水平与NO的降低水平均呈正相关(P<0.05)。以NO为T2DM血管内皮是否损伤的标准进行ROC曲线分析,IL-37、Lp-PLA2及FFA的AUC和95%CI均高于其他检测指标且差异有统计学意义(P<0.05)。结论T2DM患者血清中FFA、IL-37及Lp-PLA2等指标显著表达,NO水平显著降低与血管内皮损伤具有相关性,对T2DM血管病变的预测和筛查具有重要的临床意义。 展开更多
关键词 2型糖尿病 游离脂肪酸 白细胞介素-37 脂蛋白相关磷脂酶a2 一氧化氮
下载PDF
未足月胎膜早破患者外周血中分泌型磷脂酶A2的表达与羊膜腔感染的相关性 被引量:20
19
作者 周洋 周佳任 +2 位作者 徐漫飞 张怡舜 赵岩 《中国医科大学学报》 CAS CSCD 北大核心 2015年第6期520-523,共4页
目的研究外周血中分泌型磷脂酶A2(sPLA2)在未足月胎膜早破及羊膜腔感染中的作用及其意义。方法采用实时荧光定量PCR技术检测30例未足月胎膜早破患者(实验组)分娩发动前后、30例未发生胎膜早破的未足月正常妊娠患者(正常对照组)及30例足... 目的研究外周血中分泌型磷脂酶A2(sPLA2)在未足月胎膜早破及羊膜腔感染中的作用及其意义。方法采用实时荧光定量PCR技术检测30例未足月胎膜早破患者(实验组)分娩发动前后、30例未发生胎膜早破的未足月正常妊娠患者(正常对照组)及30例足月胎膜早破患者(足月对照组)分娩发动后外周血中sPLA2 mRNA的表达水平。未足月胎膜早破患者结束妊娠后取胎膜行病理学检查,以确定有无组织学绒毛膜羊膜炎。结果未分娩发动时sPLA2 mRNA的表达水平实验组为1.079±0.746,正常对照组为0.651±0.481,实验组与同孕周正常对照组相比sPLA2 mRNA的表达水平升高,差异有统计学意义(P=0.011)。分娩发动时外周血中sPLA2 mRNA的表达水平实验组为2.439±0.086,足月对照组为2.575±0.036,实验组与足月对照组相比sPLA2 mRNA的表达水平无统计学差异(P=0.787)。实验组中分娩发动时s PLA2的含量与是否患绒毛膜羊膜炎有关(P=0.008)。结论 sPLA2升高可能参与未足月胎膜早破的发病,并与羊膜腔的感染有关。 展开更多
关键词 胎膜早破 分泌型磷脂酶a2 绒毛膜羊膜炎 分娩发动
下载PDF
支气管扩张症合并感染患者血清人分泌型磷脂酶A2-X表达情况及其与炎性指标的相关性研究 被引量:31
20
作者 徐琳 路苹 +1 位作者 姚红梅 张翊玲 《中国全科医学》 CAS 北大核心 2020年第24期3034-3039,共6页
背景支气管扩张症是呼吸系统常见病、多发病,感染是引起支气管扩张症的最常见原因。人分泌型磷脂酶A2-X(sPLA2-X)在炎性反应中发挥重要作用,并可促进炎性反应的发生、发展,而支气管扩张症合并感染患者血清sPLA2-X表达情况及其与重要炎... 背景支气管扩张症是呼吸系统常见病、多发病,感染是引起支气管扩张症的最常见原因。人分泌型磷脂酶A2-X(sPLA2-X)在炎性反应中发挥重要作用,并可促进炎性反应的发生、发展,而支气管扩张症合并感染患者血清sPLA2-X表达情况及其与重要炎性指标如降钙素原(PCT)、C反应蛋白(CRP)、诱导型一氧化氮合酶(iNOS)、白介素(IL)-6、IL-17、IL-33是否存在相关性尚未见相关报道。目的研究支气管扩张症合并感染患者血清sPLA2-X表达情况及其与炎性指标——PCT、CRP、iNOS、IL-6、IL-17、IL-33的相关性,并进一步研究血清sPLA2-X对支气管扩张症合并感染的影响。方法选取2017年2月—2019年1月在贵州省人民医院呼吸与危重症医学科住院治疗的支气管扩张症合并感染患者47例为病例组,选取同期在贵州省人民医院健康体检中心体检的健康志愿者21例为健康对照组。收集研究对象一般资料,分别检测健康对照组体检当天、观察组治疗前(入院当天)与治疗后(出院前1天)血清sPLA2-X、白细胞计数、PCT、CRP、iNOS、IL-6、IL-17、IL-33。比较两组治疗前后观察指标,分析病例组治疗前血清sPLA2-X与PCT、CRP、iNOS、IL-6、IL-17、IL-33的相关性。结果病例组治疗前血清sPLA2-X、白细胞计数、PCT、CRP、iNOS、IL-6、IL-17、IL-33均高于健康对照组(P<0.05);病例组治疗后血清sPLA2-X、PCT、CRP、iNOS、IL-17均高于健康对照组(P<0.05);两组治疗后白细胞计数、IL-6、IL-33比较,差异无统计学意义(P>0.05)。病例组治疗后血清sPLA2-X、白细胞计数、PCT、CRP、iNOS、IL-6、IL-17、IL-33均低于本组治疗前(P<0.05)。病例组治疗前血清sPLA2-X与PCT、CRP、iNOS、IL-6、IL-17、IL-33均呈正相关(r=0.5262、0.6401、0.5507、0.5168、0.6099、0.3574,P值均<0.01)。结论支气管扩张症合并感染患者血清sPLA2-X升高,且其与PCT、CRP、iNOS、IL-6、IL-7、IL-33呈正相关,表明血清sPLA2-X与支气管扩张症合并感染有重要的关联,血清sPLA2-X可作为评估支气管扩张症合并感染的参考指标。 展开更多
关键词 支气管扩张症 感染 磷脂酶a2 分泌型 人分泌型磷脂酶a2-X 降钙素原 C反应蛋白 诱导型一氧化氮合酶 白细胞介素
下载PDF
上一页 1 2 29 下一页 到第
使用帮助 返回顶部